Document is current
Any future updates will be listed below
-
Authors
Bussin, Bram https://orcid.org/0000-0002-7441-5802
MacDuff, Marshall G. G.
Ngo, Wayne https://orcid.org/0000-0002-5755-2303
Wu, Jamie L. Y. https://orcid.org/0000-0001-7663-4964
Lin, Zachary P.
Granda Farias, Adrian https://orcid.org/0000-0003-2177-3865
Stordy, Benjamin https://orcid.org/0000-0002-1096-3287
Sepahi, Zahra
Ahmed, Sara https://orcid.org/0009-0001-8445-9016
Moffat, Jason https://orcid.org/0000-0002-5663-8586
Chan, Warren C. W. https://orcid.org/0000-0001-5435-4785
-
Funding
Funding for this research was provided by:
Canada Research Chairs (950-223824)
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 12 March 2025
First Online: 15 May 2025
Competing interests
: W.C.W.C. consults for Metis Therapeutics, Merck, Moderna, Foresight Ventures, Luna Nanotech and Cystic Fibrosis Foundation. The other authors declare no competing interests.
